Search research articles
Contact Us
Filters
Showing results (141-150 of 194) with videos related to
Page
of 20
Sort By:
Bulletin Du Cancer
|
September 30, 1998
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]
P Huc, S Block, D Carlier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
A Awada, I N Bondarenko, J Bonneterre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
Gynecologie, Obstetrique & Fertilite
|
May 17, 2005
[Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures]
S Giard, M-P Chauvet, J-L Houpeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2001
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer
T Skovsgaard, N G Davidson, M J Piccart, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial
J Bonneterre, L Mauriac, B Weber, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors
J P Peyrat, J Bonneterre, P H Vennin, et al.
The International Journal of Biological Markers
|
July 5, 2003
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients
M Hebbar, M A Krzewinski-Recchi, L Hornez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy
J Bonneterre, B Chevallier, R Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group
P F Conte, J Latreille, L Mauriac, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 194) with videos related to
Sort By:
Page
of 20
Bulletin Du Cancer
|
September 30, 1998
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]
P Huc, S Block, D Carlier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
A Awada, I N Bondarenko, J Bonneterre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
Gynecologie, Obstetrique & Fertilite
|
May 17, 2005
[Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures]
S Giard, M-P Chauvet, J-L Houpeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2001
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer
T Skovsgaard, N G Davidson, M J Piccart, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial
J Bonneterre, L Mauriac, B Weber, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors
J P Peyrat, J Bonneterre, P H Vennin, et al.
The International Journal of Biological Markers
|
July 5, 2003
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients
M Hebbar, M A Krzewinski-Recchi, L Hornez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy
J Bonneterre, B Chevallier, R Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group
P F Conte, J Latreille, L Mauriac, et al.
Page
of 20